DAVID GRAHAM to Gastrointestinal Diseases
This is a "connection" page, showing publications DAVID GRAHAM has written about Gastrointestinal Diseases.
Connection Strength
2.790
-
Update on the Use of Vonoprazan: A Competitive Acid Blocker. Gastroenterology. 2018 Feb; 154(3):462-466.
Score: 0.447
-
Rofecoxib and clinically significant upper and lower gastrointestinal events revisited based on documents from recent litigation. Am J Med Sci. 2011 Nov; 342(5):356-64.
Score: 0.291
-
Pharmacologic aspects of eradication therapy for Helicobacter pylori Infection. Gastroenterol Clin North Am. 2010 Sep; 39(3):465-80.
Score: 0.268
-
NSAIDs, risks, and gastroprotective strategies: current status and future. Gastroenterology. 2008 Apr; 134(4):1240-6.
Score: 0.227
-
Risk of low-dose aspirin: emphasis on outliers undermines the credibility of the conclusions. Aliment Pharmacol Ther. 2007 Feb 01; 25(3):345-6; author reply 346-7.
Score: 0.208
-
NSAIDs and gastrointestinal complications: new clinical challenges. Expert Opin Pharmacother. 2005 Dec; 6(15):2681-9.
Score: 0.193
-
Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut. 2006 Jun; 55(6):775-81.
Score: 0.193
-
Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment. Aliment Pharmacol Ther. 2004 May 15; 19(10):1051-61.
Score: 0.173
-
H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter. 1998 Sep; 3(3):145-51.
Score: 0.117
-
Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial. Aliment Pharmacol Ther. 2018 06; 47(11):1453-1463.
Score: 0.114
-
Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis: A Randomized Clinical Trial. Arthritis Rheumatol. 2018 04; 70(4):537-546.
Score: 0.113
-
How do clinicians practicing in the U.S. manage Helicobacter pylori-related gastrointestinal diseases? A comparison of primary care and specialist physicians. Am J Gastroenterol. 1998 Apr; 93(4):553-61.
Score: 0.113
-
Gastrointestinal symptoms and Helicobacter pylori infection in school-age children residing in Porto Torres, Sardinia, Italy. Helicobacter. 2012 Oct; 17(5):369-73.
Score: 0.076
-
Prevalence of Helicobacter (formerly Campylobacter) pylori infection in Saudia Arabia, and comparison of those with and without upper gastrointestinal symptoms. Am J Gastroenterol. 1990 Aug; 85(8):944-8.
Score: 0.067
-
Gastroduodenal complications of chronic NSAID therapy. Am J Gastroenterol. 1988 Oct; 83(10):1081-4.
Score: 0.059
-
Is the use of COX-2 inhibitors in gastroenterology cost-effective? Nat Clin Pract Gastroenterol Hepatol. 2004 Dec; 1(2):60-1.
Score: 0.045
-
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. N Engl J Med. 2016 12 29; 375(26):2519-29.
Score: 0.026
-
Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1995 Aug 15; 123(4):241-9.
Score: 0.024
-
Reverse transcription and polymerase chain reaction amplification of rRNA for detection of Helicobacter species. J Clin Microbiol. 1992 Sep; 30(9):2295-301.
Score: 0.019
-
Transmission of Helicobacter pylori infection. Studies in families of healthy individuals. Scand J Gastroenterol. 1991 Sep; 26(9):927-32.
Score: 0.018